{"id":300174,"date":"2018-12-05T12:35:12","date_gmt":"2018-12-05T12:35:12","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=300174"},"modified":"2018-12-05T12:35:12","modified_gmt":"2018-12-05T12:35:12","slug":"small-molecule-api-global-market-demand-growth-opportunities-top-key-players-and-forecast-to-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/small-molecule-api-global-market-demand-growth-opportunities-top-key-players-and-forecast-to-2027_300174.html","title":{"rendered":"Small Molecule API Global Market Demand, Growth, Opportunities, Top Key Players and Forecast to 2027"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Small Molecule API”<\/div>\n<\/div>\n<\/div>\n
WiseGuyRerports.com Presents \u201cGlobal Small Molecule API Market \u2013 Estimation & Forecast, 2013-2027\u201d New Document to its Studies Database<\/div>\n

 <\/p>\n

The global small molecule API<\/a><\/strong> market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 %<\/strong> during the forecast period. The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others.<\/p>\n

The market is majorly categorized on the basis of types which is further segmented into synthetic\/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions. 
Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016.  <\/p>\n

The scope of global small molecule API market study includes the market value, market size and a detailed analysis of vendor products and strategies. <\/p>\n

Key Players
<\/strong>The leading players of the global small molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others.<\/p>\n

<\/strong><\/p>\n

 Request For Sample Report<\/strong> @ https:\/\/www.wiseguyreports.com\/sample-request\/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027<\/a>                        <\/p>\n

                                     <\/p>\n

Study Objectives of Small molecule API Market Development and Demand Forecast to 2027 Market
<\/strong>Ø    To provide insights about factors, influencing and affecting the market growth
Ø    To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
Ø    To provide historically and forecast revenue of the market segments based on type, and sub-segment for global Small molecule API market  
Ø    To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Ø    To provide economic factors that influence the global Small molecule API market <\/p>\n

Target Audience 
<\/strong>•    Small molecule API companies 
•    Raw Material Suppliers
•    Key executive (CEO and COO) and strategy growth manager<\/p>\n

Key Findings
<\/strong>• On the basis of types, synthetic\/chemical API accounted for the largest market share of 81.31 % in 2016.
• US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period.<\/p>\n

<\/p>\n

Complete Report Details @ <\/strong>https:\/\/www.wiseguyreports.com\/reports\/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027<\/a>               <\/p>\n

 <\/p>\n

Table Of Contents:      <\/strong><\/p>\n

1 INTRODUCTION 12
1.1 DEFINITION 12
1.2 SCOPE OF STUDY 12
<\/strong>1.2.1 RESEARCH OBJECTIVE 12
1.2.2 ASSUMPTIONS & LIMITATIONS 13
1.2.2.1 ASSUMPTIONS 13
1.2.2.2 LIMITATIONS 13
1.3 MARKET STRUCTURE: 13
2 RESEARCH METHODOLOGY 14
<\/strong>2.1 RESEARCH PROCESS: 14
2.2 PRIMARY RESEARCH 15
2.3 SECONDARY RESEARCH: 15
3 MARKET DYNAMICS 16
3.1 DRIVERS 16
<\/strong>3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 16
3.1.2 GROWING TREND OF OUTSOURCING 16
3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 17
3.2 RESTRAINTS 17
3.2.1 AUSTERITY MEASURES IN EUROPE 17
3.3 OPPORTUNITIES 17
3.4 MACROECONOMIC INDICATORS 18
4 MARKET FACTOR ANALYSIS 19
<\/strong>4.1 PORTERS FIVE FORCES MODEL 19
4.2 BARGAINING POWER OF SUPPLIERS 20
4.3 BARGAINING POWER OF BUYERS 20
4.4 THREAT OF NEW ENTRANTS 20
4.5 THREAT OF SUBSTITUTES 20
4.6 INTENSITY OF RIVALRY 20
5 GLOBAL SMALL MOLECULES API, BY TYPE 21
<\/strong>5.1 SYNTHETIC\/CHEMICAL API 22
5.2 BIOLOGICAL API 23
6 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 25
<\/strong>6.1 CARDIOVASCULAR 27
6.2 ONCOLOGY 28
6.3 DIABETES 29
6.4 IMMUNOLOGICAL DISORDERS 30
7 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 31
<\/strong>7.1 IN-HOUSE MANUFACTURING 33
7.2 CONTRACT MANUFACTURING 34
7.2.1 INTRODUCTION 34
8 GLOBAL SMALL MOLECULE API MARKET, BY REGION 37
<\/strong>8.1 NORTH AMERICA 39
8.1.1 INTRODUCTION 40
8.2 EUROPE 46
8.2.1 INTRODUCTION 47
8.3 ASIA-PACIFIC 58
8.3.1 INTRODUCTION 59
8.4 MIDDLE EAST & AFRICA 72
8.4.1 INTRODUCTION 76
9 COMPETITIVE LANDSCAPE 77
<\/strong>9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 77
9.1.1 STRATEGIC PARTNERSHIP 78
9.1.2 MERGER & ACQUISITION 78
10 COMPANY PROFILE 80
10.1 ALBEMARLE CORPORATION 80
<\/strong>10.1.1 OVERVIEW 80
10.1.2 PRODUCT OVERVIEW 80
10.1.3 FINANCIALS 81
10.1.4 KEY DEVELOPMENTS 81
10.2 ALLERGAN PLC 82
<\/strong>10.2.1 OVERVIEW 82
10.2.2 PRODUCT OVERVIEW 82
10.2.3 FINANCIALS 83
10.2.4 KEY DEVELOPMENTS 83
10.3 AUROBINDO PHARMA 84
<\/strong>10.3.1 OVERVIEW 84
10.3.2 PRODUCT OVERVIEW 84
10.3.3 FINANCIALS 85
10.3.4 STRATEGY 85
10.3.5 KEY DEVELOPMENT 85
10.4 CAMBREX CORPORATION 86
<\/strong>10.4.1 OVERVIEW 86
10.4.2 PRODUCT OVERVIEW 86
10.4.3 FINANCIALS 87
10.4.4 KEY DEVELOPMENTS 87
10.5 DR. REDDY’S LABORATORIES LTD. 88
<\/strong>10.5.1 OVERVIEW 88
10.5.2 PRODUCT OVERVIEW 88
10.5.3 FINANCIALS 89<\/p>\n

 Continued…….<\/strong>                                                      <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Small Molecule API” WiseGuyRerports.com Presents \u201cGlobal Small Molecule API Market \u2013 Estimation & Forecast, 2013-2027\u201d New Document to its Studies Database   The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-300174","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/300174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=300174"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/300174\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=300174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=300174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=300174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}